Nanostructured Lipid Carriers as a Potential Topical Drug Delivery Approach
Keywords:
Nanostructured lipid carriers, drug modulation, topical drug delivery, skin occlusion, permeabilityAbstract
Topical drug delivery is a remarkable approach to treat skin diseases and to avoid pain and low patient compliance in cases where a systemic delivery is required. However, the stratum corneum, which is the outermost skin layer, strongly protects the body from the entrance of substances, especially those hydrophilic in nature. For topical application of drugs generally application on skin is one of method of administration. But problem observed that only limited drugs are active through skin penetration hence search safe drug carrier to increase its penetration power with good therapeutic activity. In the research of safe drug carrier commence with lipid based carriers, which play important role in penetration of drug as nano-carriers. Nanostructured lipid carrier’s ﴾NLC’s﴿ consist of blended solid and liquid lipids ﴾oils﴿ dispersed in an aqueous solution containing a surfactant. These carriers’ shows advantages over other topical formulation such as good biocompatibility, high permeability when used topically; low cytotoxicity, high drug content and they enhance drug stability and have many possibilities of application. This paper covers methods of preparation, advantages and disadvantages of NLC’s, modulation of drug release through skin, and objectives behind formulating the NLC’s. It also contains types of NLC’s and their applications in topical formulations.
References
Czajkowska-Ko´snik A, Szekalska M, Winnicka K. Nanostructured Lipid Carriers: A Potential Use for Skin Drug Delivery Systems. Pharmacol Rep. 2019; 71(1): 156–166p. https://doi.org/10.1016/j.pharep.2018.10.008
Raquel Petrilli, Renata Fonseca Vianna Lopez. Physical Methods for Topical Skin Drug Delivery: Concepts and Applications. Braz J Pharm Sci. 2018; 54(Special): E01008p.
Chandana Karnati V, Vishal Gupta N, Sandeep Kanna. Nanostructured Lipid Carriers: The Frontiers in Drug Delivery. Asian J Pharm Clin Res. 2019; 12(7): 8–12p.
Salve Vedanti R, Pravin Pawar. Nanostructured Lipid Carrier (NLC) System: A Novel Drug Targeting Carrier. J Drug Deliv Sci Technol. 2019; 51: 255–26p.
Amit Sharma, Ashish Baldi. Nanostructured Lipid Carriers: A Review. J Develop Drugs. 2018; 7(2): 1000191p.
Purohit Dhruv K, Nandgude Tanaji D, Poddar Sushilkumar S. Nano-lipid Carriers for Topical Application: Current Scenario. Asian Journal of Pharmaceutics. Jan–Mar 2016; (Suppl)9(5): S1–S9p.
Gordillo-Galeano A, Elizabeth Mora-Huertas C.. Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: A Review Emphasizing on Particle Structure and Drug Release. Eur J Pharm Biopharm . 2018; 133: 285–308p. doi:https://doi.org/10.1016/j.ejpb.2018.10.017
Dubey A, Prabhu P, Kamath JV. Nanostructured Lipid Carriers: A Novel Topical Drug Delivery System. Int J PharmTech Res. 2012; 4(2): 705–714p.
Nandvikar NY, Lala RR, Shinde AS. Nanostructured Lipid Carrier. The Advanced Lipid Carriers. IJPSR. 2019; 10(12): 5252–5265p.
Piyush Jaiswal, Bina Gidwani, Amber Vyas. Nanostructured Lipid Carriers and Their Current Application in Targeted Drug Delivery. Artif Cells, Nanomed Biotechnol. 2016;44(1);27-40
Elmowafy M, Shalaby K, Ali HM, Alruwaili NK, Salama A, Ibrahim MF, Ak MA, Ahmed TA. Impact of Nanostructured Lipid Carriers on Dapsone Delivery to the Skin; in vitro and in vivo Studies. Int J Pharm. 2019; 572: 118781p. doi:https://doi.org/10.1016/j.ijpharm.2019.118781
Gonza´ Lez-Mira E, Nikolic´ S, Garcia´ ML, Egea MA, Souto EB, Calpena AC. Potential Use of Nanostructured Lipid Carriers for Topical Delivery of Flurbiprofen. J Pharm Sci. Jan 2011; 100(1): 242–251p.
Uprit S, Kumar Sahu R, Roy A, Pare A. Preparation and Characterization of Minoxidilloaded Nanostructured Lipid Carrier Gel for Effective Treatment of Alopecia. Saudi Pharm J. 2013; 21(4): 379–385p. https://doi.org/10.1016/j.jsps.2012.11.005.
Downloads
Additional Files
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |